TANG CAPITAL PARTNERS LP → Jounce Therapeutics, Inc.

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

19 filings by this filer

18 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other Filings by TANG CAPITAL PARTNERS LP

Filed	Form	Issuer	Stake	Shares
2024-01-12	SC	Theseus Pharmaceuticals, Inc.	—	—	view →
2024-01-02	SC	ASLAN Pharmaceuticals Ltd	—	—	view →
2023-12-28	SC	Theseus Pharmaceuticals, Inc.	—	—	view →
2023-10-13	SC	Rain Oncology Inc.	—	—	view →
2022-07-12	SC	LA JOLLA PHARMACEUTICAL CO	—	—	view →
2021-11-26	SC	Aptevo Therapeutics Inc. APVO	—	—	view →
2021-11-22	SC	Aptevo Therapeutics Inc. APVO	—	—	view →
2021-11-19	SC	Odonate Therapeutics, Inc.	—	—	view →
2021-06-21	SC	Aptevo Therapeutics Inc. APVO	—	—	view →
2021-05-27	SC	LA JOLLA PHARMACEUTICAL CO	—	—	view →
2021-02-09	SC	Aptevo Therapeutics Inc. APVO	—	—	view →
2020-11-18	SC	Aptevo Therapeutics Inc. APVO	—	—	view →
2020-09-11	SC	LA JOLLA PHARMACEUTICAL CO	—	—	view →
2020-09-01	SC	Odonate Therapeutics, Inc.	—	—	view →
2020-06-05	SC	LA JOLLA PHARMACEUTICAL CO	—	—	view →
2019-03-12	SC	Odonate Therapeutics, Inc.	—	—	view →
2019-01-14	SC	LA JOLLA PHARMACEUTICAL CO	—	—	view →
2018-03-20	SC	LA JOLLA PHARMACEUTICAL CO	—	—	view →

TANG CAPITAL PARTNERS LP → Jounce Therapeutics, Inc.

Item 4 — Purpose of Transaction

Cross-References

Other Filings by TANG CAPITAL PARTNERS LP

Want this depth on every filing the moment it hits SEC EDGAR?